J. Russel Denton serves as Senior Vice President, General Counsel, and Secretary at Caris Life Sciences Inc., a leading precision medicine company revolutionizing cancer care through molecular profiling and AI-driven diagnostics. In this pivotal role, Denton oversees all legal, compliance, and regulatory functions, ensuring the company's innovative therapies and services navigate complex healthcare landscapes. He also acts as corporate secretary, managing board governance, shareholder relations, and strategic transactions, playing a key role in Caris's growth amid expanding molecular intelligence platforms. With over 25 years of experience in healthcare and life sciences law, Denton began his career at prominent firms such as Haynes and Boone, LLP, where he specialized in mergers and acquisitions, intellectual property, and regulatory matters for biotech and pharmaceutical clients. Prior to joining Caris in 2018, he held senior legal positions at several healthcare organizations, including roles at a major diagnostics firm and a venture-backed oncology startup, where he successfully led multi-million-dollar financing rounds, patent portfolios, and FDA approvals. His expertise has been instrumental in high-stakes deals, such as Caris's partnerships with pharmaceutical giants and expansions into new therapeutic areas. Denton's achievements include advising on groundbreaking litigation victories protecting proprietary AI algorithms and spearheading compliance programs that have positioned Caris as a leader in ethical data use for precision oncology. A graduate of the University of Texas School of Law, he is a frequent speaker on healthcare innovation law and serves on advisory boards for life sciences accelerators, underscoring his commitment to advancing patient-centric technologies.